Modulation of Autophagy as a Therapeutic Target for Alzheimer's Disease.

about

Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications.Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits.

P2860

Q50023771-9F8D5A28-6AF6-49AD-9749-48687E216EBC Q55353865-09CE506F-F338-4D1D-87E6-E01F189D41BA

P2860

Modulation of Autophagy as a Therapeutic Target for Alzheimer's Disease.

Item

http://www.wikidata.org/entity/Q38911931

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Modulation of Autophagy as a Therapeutic Target for Alzheimer's Disease.

@en

type

Item

label

Modulation of Autophagy as a Therapeutic Target for Alzheimer's Disease.

@en

prefLabel

Modulation of Autophagy as a Therapeutic Target for Alzheimer's Disease.

@en

P1476

Modulation of Autophagy as a Therapeutic Target for Alzheimer's Disease.

@en

P2093

Emily Fan

http://www.w3.org/2001/XMLSchema#string

John W Steele

http://www.w3.org/2001/XMLSchema#string

Victor Bustos

http://www.w3.org/2001/XMLSchema#string

Yildiz Kelahmetoglu

http://www.w3.org/2001/XMLSchema#string

Yuan Tian

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease

Guidelines for the use and interpretation of assays for monitoring autophagy

A comprehensive glossary of autophagy-related molecules and processes (2nd edition)

Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice

p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy

Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control

Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism

Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.

Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis

Autophagy and disease: always two sides to a problem

P304

21-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28286801

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

autophagy

P932

5342246

http://www.w3.org/2001/XMLSchema#string

Modulation of Autophagy as a Therapeutic Target for Alzheimer's Disease.

about

P2860

P2860

Modulation of Autophagy as a Therapeutic Target for Alzheimer's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932